MedPath

Contralateral myopia progression trial

Not Applicable
Conditions
Myopia
Eye - Diseases / disorders of the eye
Registration Number
ACTRN12618000242224
Lead Sponsor
Brien Holden Vision Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
10
Inclusion Criteria

Aged between 6 years to 17 years (6 years and 17 years inclusive);
Spherical equivalent -0.75 D to -3.50 D with cylinder no more than -1.00 D; anisometropia of less than or equal to 0.75D
Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent or have a parent / guardian who is able to give informed consent on the participant’s behalf.
Be willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
Have ocular health findings considered to be normal” and which would not prevent the subject from safely wearing contact lenses;
Have vision correctable to at least 6/9.5 or better in each eye with study contact lenses.

Exclusion Criteria

Participants enrolled in the trial must NOT have:
pre-existing ocular irritation that would preclude contact lens fitting;
any systemic or ocular condition or ocular injury that may preclude safe wearing of contact lenses;
undergone corneal refractive surgery;
Keratoconus
a known allergy to, or a history of intolerance to cyclopentolate or topical anaesthetics;
at baseline, astigmatism more than 1.00 D in either eye;
had strabismus and/or current ongoing amblyopia;
any ocular, systemic or other condition or disease with possible associations with myopia or affecting refractive development e.g. Marfan syndrome, retinopathy of prematurity;
current orthoptic treatment or vision training;
eye injury or surgery within 12 weeks immediately prior to enrolment for this trial;
undergone atropine treatment for myopia control;
worn bifocal or progressive addition spectacles or anti-myopia contact lenses previously;
worn orthokeratology lenses previously;
require anticholinergic medication for gastrointestinal or other conditions;
at baseline, be anisometropic by more than 0.75D;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath